Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?
Health & MedicineOne-Off1y
Manifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastNo 68.6%
Forecasters
5
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 3 hours ago
StaleFeb 21, 23, 8:24 PM UTCDec 31, 27, 10:59 PM UTC
Trends
Rules
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of colorectal adenocarcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
